A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

NCT03958890 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

489

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: HLX10 100 mg in 10 ml Injection
DRUG: Placebos

Sponsor

Shanghai Henlius Biotech